Cancer Research KI updates and upcoming events
|
|
|
|
Cancer Research KI awards the Bridging Grant at the consolidator level for a junior researcher
|
|
|
|
|
The purpose of the Bridging Grant is to give the most prominent young researchers at KI the opportunity to consolidate their research broaden their activities. To read more on the Bridging grant, please visit the website.
In the field of cancer research, Cancer Research KI awarded Linda Lindström, Associate Professor in Cancer Epidemiology and Group Leader at the Department of Oncology and Pathology. The title of the project is "Identification of key factors influencing the risk of late metastatic disease in breast cancer."
Cancer Research KI reached out to Linda Lindström to ask about her project. You can read more on the Cancer Research KI website.
|
|
|
|
|
The Karolinska Institutet and Karolinska University Hospital strengthen their relationships with the National Institute of Oncology (Hungary) in cancer research and education
|
|
In 2021, Karolinska Institutet and Karolinska University Hospital signed a Memorandum of Understanding (MoU) in the field of research and education with the National Institute of Oncology (NIO), Budapest, Hungary. The MoU applies to everything from student exchanges, joint courses and conferences, to research collaborations at various levels. The parties undertake to comply with international principles and agreements on academic freedom while aiming to strengthen all parties’ activities in the fields of education, clinical oncology and cancer research. The collaboration is managed through Cancer Research KI and the Karolinska Comprehensive Cancer Centre.
National Institute of Oncology (NIO) profile and strengths
NIO is the only OECI-accredited Comprehensive Cancer Centre in Eastern Europe. The institute's activities include care development, registry coordination and research in all fields of cancer for the whole of Hungary, with around 10 million people. NIO specializes in cancer biomarkers, the national patient registry in Hungary, radiology and radiotherapy. Approximately 1000 people work at NIO, and there are 350 patient beds. Redox biology, genomics and cancer genomics are strong fields of research conducted in 8 departments, and NIO performs many clinical trials.
Beating Cancer Plan and Cancer Mission Initiative
Europe’s new “Beating Cancer Plan” and “Cancer Mission” initiatives, with a total budget of ca. €4 billion, encourage partnerships of cancer centres and researchers between Western and Eastern Europe, where the MoU can form a good foundation for further collaborations between Stockholm and Budapest. Joint applications for financial support of exchange and collaborations between the institutions have been submitted, and hopefully, the coming years will enable us to fill the MoU with many different interesting and productive activities.
|
|
Karolinska Clinical Cancer Talks
|
|
Welcome to the Karolinska Clinical Cancer talks with Professor Yvonne Wengström on 'Precision health- exercise and treatment for cancer'.
25th April 2022 16.00-16.45
Sune Bergströms Aula J3:07 Solna or Teams
Please e-mail cancerresearchki@ki.se to get the teams link
Karolinska Comprehensive Cancer Center leads “Karolinska Clinical Cancer Talks”, where distinguished cancer researchers give talks on topics in cancer research for cancer researchers and clinicians in cancer care. While the topics may be highly specialized, the presentations should be understandable for all with training in cancer biology, oncology, and oncologic surgery. The talks are given in English. Photo: Martin Stenmark
|
|
|
|
|
|
Cancer workshop for patient organisations
|
|
This joint workshop between Cancer Research KI and RCC Stockholm-Gotland aims to address opportunities for interaction and communication between different patient organisations, researchers and the general public.
This event will be held on the 6th of April 2022 via zoom. All presentations and discussions will be in Swedish. For more information and the programme please visit our website.
|
Recent Research Publications
|
| • |
Songbai Zhang (Dept. of Medical Biochemistry and Biophysics) et al., GIT1 protects against breast cancer growth through negative regulation of Notch. Nature Communications, March 2022.
| | • |
Jianjiang Hu (Dept. of Biosciences and Nutrition) et al., Local temporal Rac1-GTP nadirs and peaks restrict cell protrusions and retractions. Science Advances, March 2022
| | • |
Marie-Stéphanie Aschtgen (Dept. of Microbiology, Tumor and Cell biology) et al., Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization. Oncogene, February 2022.
| | • |
Theresa Mader (Dept. of Physiology and Pharmacology) et al., Exercise reduces intramuscular stress and counteracts muscle weakness in mice with breast cancer. J Cachexia Sarcopenia Muscle, February 2022.
| | • |
Christina-Evmorfia Kampitsi (Institute of Environmental Medicine) et al., The relationship between congenital heart disease and cancer in Swedish children: A population-based cohort study. PLoS Med, February 2022.
| | • |
Johan Erlandsson (Dept. of Molecular Medicine and Surgery) et al., Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial. BJS Open, November 2021.
| | • |
Aiva Lundberg Båve (Dept. of Medicine Huddinge) et al., Increased risk of cancer in patients with primary sclerosing cholangitis. Hepatol Int., October 2021.
| | • |
Per Nilsson (Dept. of Molecular Medicine and Surgery) et al., Organ preservation following short-course radiotherapy for rectal cancer. BJS Open, October 2021.
| | • |
Emma Rosander (Dept. of Molecular Medicine and Surgery) et al., Preoperative multidisciplinary team assessment is associated with improved survival in patients with locally advanced colon cancer; a nationwide cohort study in 3157 patients. Eur J Surg Oncol., September 2021.
|
Any cancer-related publications from a KI-based researcher (corresponding author must be from KI) that you wish to be advertised through our newsletter please send in the format shown above to our email: cancerresearchki@ki.se
|
|
|
|
|
Please send us your open positions for Master's projects, PhD candidates and postdocs so that we can advertise them to our Cancer Research KI community.
|
|
|
|
|
|
|
|
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, conducted by some 350 research groups at multiple campuses and departments. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
|
|
|
|
|
|
|
